All About Scale: GSK Eyes China Partnerships To Ramp Up Vaccine Access

Wider Roll-Out Amid Rising Competition

 
• By Brian Yang

GSK is betting on a new partnership to more quickly ramp up patient access to its vaccines in the potentially vast market of China, amid rising demand and competition.

Shingles vaccine
GSK bets on fast scale-up of vaccines access in China • Source: Alamy

More from China

More from Focus On Asia